KP
Kyle Piskel
Chief Financial Officer

Kyle Piskel insider trades: Adaptive Biotechnologies (ADPT) stock sales

Chief Financial Officer, Adaptive Biotechnologies Last trade May 18, 2026 18 Form 4 filings
$3.6M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kyle reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 18, 2026ADPT↓ Sell$41K
Mar 11, 2026ADPT↓ Sell$246K
Feb 4, 2026ADPT↓ Sell$40K
Jan 12, 2026ADPT↓ Sell$77K
Nov 28, 2025ADPT↓ Sell$3.2M
Nov 17, 2025ADPT↓ Sell$3K
May 16, 2025ADPT↓ Sell$17K
Mar 5, 2025ADPT↓ Sell$72K
Nov 18, 2024ADPT↓ Sell$1K
Mar 5, 2024ADPT↓ Sell$27K
Nov 16, 2023ADPT↓ Sell$1K
Mar 6, 2023ADPT↓ Sell$30K
Nov 16, 2022ADPT↓ Sell$9K
Mar 7, 2022ADPT↓ Sell$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ADPT insiders

Open-market trades in the last 12 months

About Kyle Piskel's insider trades

Kyle Piskel is Chief Financial Officer at Adaptive Biotechnologies (ADPT). Since Mar 7, 2022, Kyle has reported no open-market purchases and 14 sales worth $3.7M on SEC Form 4. In the last 12 months: 6 sales ($3.6M).

Their filings also include grants and awards (8 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.